Explore 3 Stock Ideas & Industry Insights Download Free Report

Gabelli Healthcare & WellnessRx Trust

Company price
9.96 USD -0.11 ( 1.09%)
Last update at 2026-11-20T21:00:00Z
VOLUME
9895
Market Cap
138.62M
P/E
61.40

Momentum Score

…

The Gabelli Healthcare and Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
9.96
Low
10.28
High
52 Week Price Range
8.46
Low
9.87
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Gabelli Healthcare and WellnessRx Trust is a closed-end investment company that primarily holds equities of healthcare and consumer wellness companies to pursue long-term capital appreciation and income. The trust may benefit from aging populations, rising healthcare spending and expanding consumer wellness demand, while active management and regular distributions could appeal to income-focused investors.
Principal risks include sector concentration, sensitivity to regulatory and clinical outcomes, and fund-level factors such as leverage and the possibility of shares trading at a discount or premium to net asset value.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
10.07
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
0.45
ROE
-1374.10%
Net Debt
70.70M
ROCE
2.07%
Diluted EPS TTM
0.15

Insight Announcement

Saba Capital Buys 1,056 GRX Shares at $10.21

Vinay Lochav | 2 days, 9 hours ago
View All

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 2.29M -0.28M 0.42M -47.44M 42.74M
Net income 2.29M -0.28M 0.42M -47.44M 42.74M
Selling general administrative 0.48M 0.42M 0.54M 0.73M 0.75M
Gross profit 12.79M 0.34M 1.24M -46.71M 43.49M
Ebit - - 3.04M - -
Ebitda 4.77M 2.68M 3.20M -44.26M 42.74M
Depreciation and amortization - - 0.17M - -
Operating income 4.74M 2.68M 3.20M -44.26M 42.74M
Other operating expenses 10.53M 3.54M 3.59M 0.73M 0.75M
Interest expense 2.47M 2.92M 2.77M 3.18M 1.94M
Interest income 0.84M 0.38M 0.64M 0.46M 44.95M
Net interest income -1.61M -2.54M -2.14M -2.72M -1.93M
Income tax expense - - -0.17M - -
Total revenue 15.28M 3.26M 4.01M -46.71M 43.49M
Total operating expenses 8.05M 0.63M 0.82M 0.73M 0.75M
Cost of revenue 2.48M 2.92M 2.77M - 5.00M
Total other income expense net -2.45M -2.97M -2.78M -3.18M -1.94M
Net income from continuing ops 2.29M -0.29M 0.42M -47.44M 42.74M
Net income applicable to common shares - - - - 42.74M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 241.89M 225.71M 239.04M 248.70M 350.84M
Other current assets - 0.01M 0.01M - -
Total liab 83.38M 54.85M 54.23M 44.04M 86.88M
Total stockholder equity 158.51M 170.86M 184.81M 204.65M 263.95M
Other current liab 0.48M -0.01M -0.00M -3.53M -6.23M
Common stock 105.49M 110.02M 114.34M 125.10M 126.82M
Capital stock 105.49M 110.02M 114.34M 125.10M 126.82M
Retained earnings 53.02M 60.85M 70.47M 79.55M 137.13M
Other assets - 225.71M 239.04M 0.16M 0.15M
Cash 0.02M - 0.00M 0.05M -
Total current liabilities 12.52M 0.18M 0.00M 3.53M 6.23M
Current deferred revenue - - -0.03M - -
Net debt 70.70M 0.01M 53.32M -0.05M 0.07M
Short term debt - 0.01M 0.00M - 0.07M
Short long term debt total 70.72M 0.01M 53.32M - 0.07M
Total current assets 0.41M 0.43M 0.78M 6.68M 0.48M
Long term investments 241.15M 224.96M 238.11M 241.86M 350.22M
Net receivables 0.39M 0.42M 0.77M 6.63M 0.48M
Long term debt - - - - 80.00M
Accounts payable 12.04M 0.18M 0.03M 3.53M 6.23M
Non currrent assets other 0.33M 0.32M 0.16M -241.86M -350.22M
Non current assets total 241.48M 225.28M 238.26M 241.86M 350.22M
Long term debt total - - - - 80.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total cashflows from investing activities 67.63M 18.34M -0.07M - -
Net borrowings -0.01M 0.01M - - -
Total cash from financing activities 2.11M -13.11M -6.66M -58.06M 18.93M
Net income 2.29M -0.28M 0.42M -47.44M 42.74M
Change in cash 0.02M -0.00M -0.05M 0.05M -0.01M
Begin period cash flow 0.00M 0.00M 0.05M 0.00M 0.01M
End period cash flow 0.02M 0.00M 0.00M 0.05M 0.00M
Total cash from operating activities 9.43M -2.33M -0.36M 58.11M -18.94M
Issuance of capital stock 16.69M 10.35M 13.32M - 40.00M
Other cashflows from investing activities - - 0.00M - -
Dividends paid 10.15M 9.37M 9.94M -16.47M -16.52M
Change to account receivables 0.03M 0.35M 5.85M - -
Sale purchase of stock -4.37M -4.47M -9.94M -41.60M -4.41M
Other cashflows from financing activities -0.02M 0.71M 13.22M - 39.86M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 11.80M 0.25M 2.43M -2.80M 7.23M
Other non cash items -4.66M -2.29M -3.21M 108.35M -68.91M
Free cash flow 9.43M 13.11M -0.36M 58.11M -18.94M

Peer Comparison*

Sector: Financial Services Industry: Asset Management

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
GRX
Gabelli Healthcare & WellnessRx Trust
-0.11
1.09%
9.96 61.40 - 47.48 0.86 45.85
BLK
BlackRock Inc
-33.46
2.95%
1102.35 26.25 19.57 6.33 2.90 6.35
BX
Blackstone Group Inc
-0.01
0.01%
110.80 33.20 20.12 11.05 11.56 9.14
IVSBF
Investor AB ser. B
-1.22
2.98%
39.70 4.67 3.83 3.78 1.13 4.15
KKR
KKR & Co. Inc.
-3.60
3.91%
88.53 32.68 13.66 3.58 3.22 0.68

Profile*

Gabelli Healthcare & WellnessRx Trust

The Gabelli Healthcare and Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.

One Corporate Center, Rye, NY, United States, 10580-1422

914 921 5000

Name Title Year Born
Mr. Wayne Christopher Pinsent C.F.A. Assistant VP and Ombudsman 1986
Mr. Mario Joseph Gabelli C.F.A., CFA Portfolio Mang. 1943
Mr. Bruce N. Alpert CPA, CPA Exec. VP & Chief Operating Officer 1952
Mr. Adam E. Tokar VP 1980
Mr. Carter W. Austin Sr. VP 1966
Mr. David I. Schachter VP 1953
Mr. Kevin V. Dreyer Portfolio Mang. NA
Mr. Jeffrey J. Jonas Jr., C.F.A., Jr. Portfolio Mang. NA
Mr. Wayne Christopher Pinsent C.F.A. Assistant Vice President and Ombudsman 1986
Mr. Mario Joseph Gabelli C.F.A. Portfolio Manager 1942

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…